Where your money goes

Thanks to the generosity of our amazing supporters, in 2017-18 we raised £773,812. We are very careful about where we spend every penny given to us through your generous donations.

In 2017-18, we awarded research grants for a over £457,000 - read more about some of the research we funded in 2018.

You can find out more detailed information about our finances in our reports below.

2018 Finances

Our annual review of 2017/18 contains news, stories, developments in eye research and a summary of our finances. Click the image below to read it online or download.

For more information and detail on the National Eye Research Centre finances, you can download a copy of our full financial statements and report for the year ending 30 June 2018.

2017 Finances

Read our 2017 Annual Review here.

Read our 2017 full financial statements here.

2016 Finances

Read our 2016 Annual Review here.

Read our 2016 full financial statements here.

Together, we can beat sight loss forever.

Please help us fund vital research to develop new prevention methods and more effective treatments.

Donate

Latest

Seeing again after a Corneal Transplant

Margaret Hancock’s story illustrates why more funding is needed to bring about breakthrough eye treatments which can enhance the eye health of the nation.
Funding Programmes open to applications

Seed grants deadline: 30th November

First Stage major grants and PhD studentships deadline: 31st October
New drugs to treat mitochondrial optic neuropathies

A further study by Professor Marcela Votruba at Cardiff University is looking for sustained release formulations for new drugs to treat mitochondrial optic neuropathies
Identifying risk factors for retinal detachment

Dr Veronique Vitart at the University of Edinburgh is looking to identify genetic mutations that increase risk factors of retinal detachment.

Glaucoma

Glaucoma is the most common cause of sight loss amongst those of working age. Pressure is raised in the eye which damages the optic nerve and increasingly causes sight loss. New treatments, including improved eye drops and surgical techniques to reduce this pressure in the eye are being researched.
Age-related macular degeneration

Age-related macular degeneration (AMD) is a painless eye condition that leads to the gradual loss of central vision. Around 600,000 people in the UK currently have sight loss caused by AMD and around 70,000 new cases are diagnosed every year.
Cataracts

Cataracts occur when changes in the lens of the eye cause it to become less transparent. This results in cloudy or misty vision. Cataracts are the leading cause of blindness globally but can be easily treated.
Uveitis

Uveitis is a leading cause of visual impairment in people of working age in the UK. It is an inflammation of the middle layer of the eye, called the uvea or uveal tract.
Dry Eye Syndrome

Dry eye syndrome, or dry eye disease, is a common condition that occurs when the eyes don't make enough tears, or the tears evaporate too quickly. This leads to the eyes drying out and becoming red, swollen and irritated. Dry eye syndrome is also known as keratoconjunctivitis sicca.
Corneal Disease

The cornea is the clear tissue at the front of the eye that lets in light and helps focus it on the retina so that we can see. Disease or injury can make the cornea cloudy or distorted in shape, causing a loss of vision. A cornea transplant replaces diseased corneal tissue with a disc of healthy tissue from a donor.
Retinitis pigmentosa

Retinitis pigmentosa (RP) is the name given to a group of inherited conditions of the retina that all lead to a gradual progressive reduction in vision.
Amblyopia

A lazy eye, also known as amblyopia, is a childhood condition that occurs when the vision in one eye does not develop properly.
Research Grants Funding
National Eye Health Week 2019

23 - 29 September 2019 is National Eye Health Week. The week will provide plenty of tips on protecting your eye health and how research is helping to combat blindness.